Suven Pharma Q2 Results: Net profit rises 3% to Rs 82 crore

PE firm Advent backed Suven Pharma net profit rose 3% year-on-year (YoY) to Rs 82 crore in Q2FY25 compared to Rs 79.6 crore in the corresponding period of the previous year.